EI
PCRX icon

EAM Investors’s Pacira BioSciences PCRX Stock Holding History

EAM Investors’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45,145
Closed -$3.44M – 327
2022
Q1 		$3.44M Buy
+45,145
New +$3.01M 0.64% 23
2020
Q4 		– Sell
-26,798
Closed -$1.61M – 367
2020
Q3 		$1.61M Sell
26,798
-10,339
-28% -$601K 0.38% 91
2020
Q2 		$1.95M Buy
+37,137
New +$1.55M 0.43% 89
2016
Q1 		– Sell
-39,026
Closed -$3M – 328
2015
Q4 		$3M Buy
+39,026
New +$2.21M 0.39% 116
2015
Q1 		– Sell
-20,604
Closed -$1.83M – 380
2014
Q4 		$1.83M Buy
20,604
+2,340
+13% +$221K 0.25% 179
2014
Q3 		$1.77M Sell
18,264
-4,937
-21% -$480K 0.36% 87
2014
Q2 		$2.13M Sell
23,201
-11,254
-33% -$857K 0.4% 57
2014
Q1 		$2.41M Sell
34,455
-6,374
-16% -$434K 0.43% 55
2013
Q4 		$2.35M Sell
40,829
-20,686
-34% -$1.09M 0.42% 62
2013
Q3 		$2.96M Sell
61,515
-3,126
-5% -$114K 0.59% 25
2013
Q2 		$1.88M Buy
+64,641
New +$1.87M 0.41% 63

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return